• A better world

    FAIL-SAFE INFUSION

  • The CYTO360 IV-set

    IV -set on the market today allows unintentional mixing of drug fluids when secondary infusions accidentally are administrating in parallel.

    The "CYTO360 medical stopcock" is a multigang manifold in turn-valve configuration. Forcing multiple secondary infusions to be administered in series.

    Administration error

    Mission: Risk prevention of IV -set with a fail-safe design

    Human factors

     

    Administration error related to open and closing drug flow to the patient probably follow the same error rate as standardized by human factors experts. Humans make 1 error per 100 actions. Administration errors occur probably more often then we think. If your IV -set allows more then one drug flow to the patient then it is likely that administration errors happens daily already with your IV -set or stopcock arrangements (multigang manifolds).

     

     

    "My innovation CYTO360 is probably a direct result of my interests in human factors and seeing the problem in a different way. As an airline pilot you are always making mistakes, because they are so many mistakes to be done. And so it is for all workplaces not least at a hospital. Whenever possible we must have fail-safe infusion system to catch these errors" - Micael Törnblom

    Continues drug incompatibility

    Mission: Reduce the risk of mixing drugs when administrating infusion

    COCKTAIL EFFECT

     

    Most infusion treatments never require multiple drug infusion at the same time. In fact there is a great risk with unintentionally mixing drugs. It is called “drug incompatibility” and can cause a cocktail effect, with enhanced or reduced effect of the drug or even a new compound can form with no knowledge of its effect.

     

  • CYTO360 VIDEO

    Request access by filling in the form below or send an e-mail to info@cyto365.com

    The CYTO360 medical stopcock by CYTO365 AB has been awarded 1st price of Venturecup and nominated to Alfred Nobel SKAPA stiftelse 2012.

    In cooperation with AWA Patent, ALMI and proved trackrecord with one of the world largest medtech company.

  • Patent granted

    PROTECTED IN 148 COUNTRIES

  • IP partner

    Business Partner

    Awards

    Awards

  • LICENSE OF PATENTS


    There are 22 countries listed already by a global medtech company for exclusive rights to manufacture and sell the CYTO360 medical stopcock including main parts of Europe, Australia, Russia and China.

     

    However there are still high valued markets available such as; North America, Japan, Eurasia, Africa, the Middle East and India to name a few.

     

    Contact us for more information on how you can be non exclusive or exclusive distributor or manufacturer of the CYTO360 medical stopcock valve.

  • COMMUNICATIONS

    CYTO365 AB, C/O Micael Törnblom, Bergstensgatan 2, 263 65 Viken, Sweden

    Phone

     

    +46 709 64 66 73

     

    Twitter

     

    @cyto365

     

    Linked in

     

    @micaeltornblom

     

  • CYTO365

    CYTO365 is a distruptive startup that innovates fail-safe medical devices

    Micael Törnblom

    Founder, CEO

  • CONTACT FORM

    Make a request today for more information